Market closedNon-fractional

Catalent/CTLT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Catalent

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

Ticker

CTLT

Sector

Healthcare

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Somerset, United States

Employees

17,800

Catalent Metrics

BasicAdvanced
$11B
Market cap
-
P/E ratio
-$6.47
EPS
1.20
Beta
-
Dividend rate
$11B
1.2
2.505
1.03
136.61
138.189
-0.32%
-0.48%
-28.29%
2.559
2.92
26.53
-86.043
-8.01%
-5,615.29%
3.24%
29.83%

What the Analysts think about Catalent

Analyst Ratings

Majority rating from 11 analysts.
Hold

Catalent Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-9.40% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$1.1B
4.88%
Net income
-$101M
-50.97%
Profit margin
-9.40%
-53.26%

Catalent Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 128.72%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$0.09
-$0.10
-$0.24
-$0.06
-
Expected
$0.10
-$0.14
-$0.02
$0.21
$0.53
Surprise
-13.04%
-26.55%
1,055.57%
-128.72%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Catalent stock?

Catalent (CTLT) has a market cap of $11B as of July 23, 2024.

What is the P/E ratio for Catalent stock?

The price to earnings (P/E) ratio for Catalent (CTLT) stock is 0 as of July 23, 2024.

Does Catalent stock pay dividends?

No, Catalent (CTLT) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next Catalent dividend payment date?

Catalent (CTLT) stock does not pay dividends to its shareholders.

What is the beta indicator for Catalent?

Catalent (CTLT) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Catalent stock

Buy or sell Catalent stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing